CLASS II ONGOING Device recall · Reported 3 Jun 2020 · FDA Enforcement Report

Sprotte Needle recalled by Teleflex Medical

Teleflex Medical is recalling Sprotte Needle, distributed nationwide in the US. The recall was initiated on 11 Oct 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot/Batch Numbers: 74A1900698, 74C1902955, 74C1900349, 74C1900137, 74E1802338, 74G1802129, 74H1802488, 74K1800901, 74K1801734, 74L1802219
Quantity recalled4227 devices

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2129-2020
FDA event ID
85551
Recalling firm
Teleflex Medical, Morrisville, NC
Classification
Class II
Status
Ongoing
Recall initiated
11 Oct 2019
FDA classified
26 May 2020
Reported
3 Jun 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility
Device type
Spinal Implants

Timeline

11 Oct 2019Recall initiated by company
26 May 2020Classified by FDA+228 days
3 Jun 2020Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Teleflex received the attached Medical Device Recall Notice from Pajunk Medical. Teleflex Medical is a distributor of Pajunk products. According to the notice, Pajunk internally identified a packaging problem that may affect certain batches of the SPROTTE lumbar puncture cannulas with introducer. Due to this problem Pajunk cannot guarantee the sterility of the affected batches.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Sprotte Needle, REF 32115130C w/ Intro 22 G x 3.5", distributed by Teleflex Medical The SPROTTE lumbar puncture needles are intended to gain entry into or puncture the spinal cavity permitting injection (including anesthesia) / withdrawal of fluids for purposes of diagnostic lumbar puncture, myelography/discography procedures.

Where it was distributed

Nationwide distribution.

Nationwide

Questions about this recall

Is Sprotte Needle recalled?

Yes. Teleflex Medical recalled Sprotte Needle on 11 Oct 2019. The recall is Class II and its status is Ongoing. Recall number Z-2129-2020.

Why was it recalled?

Teleflex received the attached Medical Device Recall Notice from Pajunk Medical. Teleflex Medical is a distributor of Pajunk products. According to the notice, Pajunk internally identified a packaging problem that may affect certain batches of the SPROTTE lumbar puncture cannulas with introducer. Due to this problem Pajunk cannot guarantee the sterility of the affected batches.

Which lots are affected?

Lot/Batch Numbers: 74A1900698, 74C1902955, 74C1900349, 74C1900137, 74E1802338, 74G1802129, 74H1802488, 74K1800901, 74K1801734, 74L1802219

Where was it sold?

Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Teleflex Medical

All 235

Other Spinal Implants recalls

All 1,157